Yubo International Biotech (YBGJ) Stock Price, News & Analysis

Company Overview

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

Key Stats

• Today's Range: $0.05 to $0.08
• 50-Day Range: $0.04 to $0.09
• 52-Week Range: $0.03 to $1.37
• Volume: 2,622 shs
• Average Volume: 11,218 shs
• Market Capitalization: $9.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Yubo International Biotech Stock Analysis - MarketRank™

Yubo International Biotech scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Yubo International Biotech.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Yubo International Biotech is -7.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Yubo International Biotech is -7.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Yubo International Biotech has been sold short.

Short Interest Ratio / Days to Cover

Yubo International Biotech has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Yubo International Biotech has recently increased by 200.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Yubo International Biotech does not currently pay a dividend.

Dividend Growth

Yubo International Biotech does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the float of Yubo International Biotech has been sold short.

Short Interest Ratio / Days to Cover

Yubo International Biotech has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Yubo International Biotech has recently increased by 200.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Yubo International Biotech has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Yubo International Biotech this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Yubo International Biotech insiders have not sold or bought any company stock.

Percentage Held by Insiders

68.50% of the stock of Yubo International Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

YBGJ Stock Analysis - Frequently Asked Questions

How have YBGJ shares performed this year?

Yubo International Biotech's stock was trading at $0.0347 at the start of the year. Since then, YBGJ stock has increased by 121.9% and is now trading at $0.0770.
View the best growth stocks for 2025 here.

How do I buy shares of Yubo International Biotech?

Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Yubo International Biotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yubo International Biotech investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Bank of America (BAC).

Company Calendar

• Today: 5/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:YBGJ
• CIK: 895464
• Web: www.yubogroup.com
• Phone: (640) 677-6010
• Fax: 516-595-1159
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.20 million
• Net Margins: N/A
• Pretax Margin: -8,254.97%
• Return on Equity: N/A
• Return on Assets: -121.41%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $610,000.00
• Price / Sales: 12.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: -3.06

Miscellaneous

• Outstanding Shares: 119,821,000
• Free Float: 52,146,000
• Market Cap: $7.33 million
• Optionable: Not Optionable
• Beta: 4.17